Blar i St. Olavs hospital på tidsskrift "European Journal of Haematology"
Viser treff 1-4 av 4
-
Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group
(Peer reviewed; Journal article, 2021)Objective We investigated the efficacy and safety of carfilzomib-containing induction before salvage high-dose melphalan with autologous stem-cell transplantation (salvage ASCT) and maintenance with carfilzomib and ... -
Highly expressed genes in multiple myeloma cells – what can they tell us about the disease?
(Peer reviewed; Journal article, 2022)Cancer cells can convert proto-oncoproteins into oncoproteins by increasing the expression of genes that are oncogenic when expressed at high levels. Such genes can promote oncogenesis without being mutated. To find ... -
Patterns of previous and secondary malignancies in patients with multiple myeloma
(Peer reviewed; Journal article, 2021)Objectives: In contrast to secondary primary malignancies (SPM) following multiple myeloma (MM), less is known about previous malignancies. We therefore conducted a population-based study to assess the patterns of previous ... -
Risk of multiple myeloma and other malignancies among first- and second-degree relatives of patients with multiple myeloma: A population-based study
(Peer reviewed; Journal article, 2022)Objectives We conducted a population-based study to assess the risk for multiple myeloma (MM) and other cancers in first- and second-degree relatives of MM patients, and to investigate whether evidence of anticipation is ...